Genmab A/S Sponsored ADR (GMAB)
NASDAQ
Closed
Aug 24, 2026
Day's Range
32.7452 wk Range
23.62Overview - GMAB - Genmab A/S Sponsored ADR
Key Statistics
Valuation
Enterprise Value
23.73B
P/E (Trailing)
‪26.54‬
P/E (Forward)
‪21.03‬
PEG Ratio
‪-2.88‬
Price / Sales (TTM)
‪4.97‬
Price / Book
‪3.35‬
EV / EBITDA
‪17.23‬
Profitability
Gross Margin
‪92.72%‬
Profit Margin
‪19.07%‬
Operating Margin
‪35.23%‬
Return on Assets
‪8.78%‬
Return on Equity
‪13.99%‬
Ownership
Shares Outstanding
62.35M
Float
589.60M
Short % of Shares Outstanding
‪1.20%‬
Held by Insiders
‪0.00%‬
Held by Institutions
‪16.87%‬
Price stats
Beta
‪0.68‬
50-Day Avg
‪28.75‬
200-Day Avg
‪29.14‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
11 analysts
Shariah Compliance
Report Date: Feb 17, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - GMAB - Genmab A/S Sponsored ADR
Peers - GMAB - Genmab A/S Sponsored ADR
Peer Comparison
Compared with companies in Biotechnology listed on NASDAQ.
- GMABNASDAQGenmab A/S17.80BMarket Cap+26.00%52-week change22.14P/E (Trailing)‪21.04%‬Profit Margin
- ARGXNASDAQargenx SE American Depositary Receipt62.93BMarket Cap+33.08%52-week change39.69P/E (Trailing)‪32.26%‬Profit Margin
- ALNYNASDAQAlnylam Pharmaceuticals Inc31.58BMarket Cap-87.93%52-week change40.23P/E (Trailing)‪16.12%‬Profit Margin
- BNTXNASDAQBioNTech SE29.28BMarket Cap+9.87%52-week change160.80P/E (Trailing)‪-63.63%‬Profit Margin
- ASNDNASDAQAscendis Pharma A/S16.61BMarket Cap+23.98%52-week change19.38P/E (Trailing)‪70.84%‬Profit Margin
- BBIONASDAQBridgeBio Pharma, Inc.15.93BMarket Cap+41.98%52-week change-21.56P/E (Trailing)‪-97.02%‬Profit Margin
- BMRNNASDAQBiomarin Pharmaceutical Inc.12.91BMarket Cap+12.29%52-week change180.27P/E (Trailing)‪2.14%‬Profit Margin
Profile Summary - GMAB - Genmab A/S Sponsored ADR
About
Genmab A/S American Depositary Shares represent shares in Genmab A/S, a Copenhagen-based international biotechnology company founded in 1998 that specializes in creating, developing, and commercializing innovative antibody therapeutics to treat cancer and other serious diseases. The company leverages proprietary…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
